About
Our mission
Governance
Partners
Science
Our Genome Engineering Platform
TALEN® Technology
In-House Manufacturing
Pipeline
Product Candidates
Investors
IR Overview
News
Press releases
Events and Webcasts
Presentations
Corporate presentations
Scientific presentations
Scientific publications
Corporate Governance
Board of Directors
Executive Committee
External Auditors
Governance Documents
General meetings
Financial Information
SEC filings
Financial statements
Voting Rights & Share Capital
Stock information
Shareholders Services
IR Inquiries
IR FAQ
Careers
Our culture
Job opportunities
Contact us
FR
Recherche
›
Investors
›
Scientific presentations
About
Our mission
Governance
Partners
Science
Our Genome Engineering Platform
TALEN® Technology
In-House Manufacturing
Pipeline
Product Candidates
Investors
IR Overview
News
Press releases
Events and Webcasts
Presentations
Corporate presentations
Scientific presentations
Scientific publications
Corporate Governance
Board of Directors
Executive Committee
External Auditors
Governance Documents
General meetings
Financial Information
SEC filings
Financial statements
Voting Rights & Share Capital
Stock information
Shareholders Services
IR Inquiries
IR FAQ
Careers
Our culture
Job opportunities
Contact us
FR
Scientific presentations
All
2026
2025
2024
2023
2022
2021
12
Nov 2021
16:45 E.S.T.
Mesothelin (MSLN) Targeting Allogeneic CAR T Cells Engineedred to Overcome Tumor Immunosuppressive Microenvironment- SITC 2021- Poster Presentation
Download the PDF file
27
Oct 2021
13:15 E.S.T.
Preclinical development of a TALEN-based genome editing therapy for RAG1 deficiency – ESGCT 2021- Oral Presentation
Download the PDF file
Posts pagination
← PREV
1
…
4
5
6
Scientific publications
Discover Cellectis' scientific publications
Learn more
